Back to Feed
ClinicalTrials.gov|Clinical Trial
A Pilot Study of Emapalumab for the Treatment of CAR T-Cell Therapy-Associated Prolonged Cytopenia
M.D. Anderson Cancer Center
Abstract
To look at the safety and effectiveness of emapalumab for the treatment of prolonged severe cytopenia in participants with LBCL who receive CART. Phase: PHASE2 Status: RECRUITING Conditions: Cytopenia Interventions: Emapalumab
Keywords
Cytopenia